health
Study maps four genomic groups in mucosal melanoma
A bioRxiv preprint reports four genomic subtypes of mucosal melanoma and immune-cell patterns associated with disease progression and immunotherapy resistance. The findings point to TIM-3 as a possible research target, not an established treatment.